Schedule

09:30 - Welcome Address & Virtual Conference Platform Instructions

TEXT ANALYTICS AND INDUSTRY 4.0

09:40 – Improving Consumer Experience for Medical Information using Text Analytics

• A strong business need to efficiently consolidate customer feedback from HCP, Patients, etc.
• Unstructured data in form of medical / customer inquiry data
• Significant time and effort is spent in manually tagging / classifying data
• Leveraging Advanced & Text Analytics to better equip medical information teams

PRATHAMESH KARMALKAR, Principal Data Scientist - Text Analytics, Merck KGaA

10:10 – Industry 4.0 application in Pharma Manufactucturing arena
ADITYA KHADILKAR, Program Lead - Digital Transformation, Dr. Reddy's Laboratories 

10:40 – Morning Coffee/Tea & Discussion

CHALLENGES & OPPORTUNITIES

11:00 – DISCUSSION WITH EXPERTS: AI & IoT – Challenges, Opportunities and Implementation

• How is AI resolving the tech problems faced by the industry? How will the near future be?
• How is AI being put to utilize in the battle against the epidemic?
• Application of AI to clinical trial and Real-World Data - Blurring the boundaries
• How can AI change the Pharma industry?
• Challenges in AI, especially a lack of data integration and access of data?
• Major threats and challenges of drug discovery by AI
• Huge data delivered by IoT devices, how are they to be handled – data secured?
• Remote Patient monitoring via IoT made simpler
• What’s instore for us with this AI & IoT for this era?

Moderator:
VINAY WANDREKAR, Business Information Security Expert, Novartis

Panellists:
MANU GUPTA, Vice President – Information Technology, Cadila
BIJENDER KUMAR MISHRA, Chief Information Security Officer, Alkem Laboratories
DHAVAL PANDYA, Corporate CIO, Piramal
VAIBHAV RAO, Asia Digital Client Partner, Pfizer
JON LEE-DAVEY, Global IoT Healthcare Lead, Vodafone (UK)
RAMINDERPAL SINGH, Founder, Incubate.bio (UK)
ASHUTOSH INAMDAR, Senior General Manager Strategy, Lupin

12:10 – Patient recruitment using AI for clinical trials & How can AI change the Pharma industry

•  How AI can improve clinical trials
• How does future looks like
• How AI is changing the Pharma industry

VARUN CHUGH, Director Technology Transformation, Novartis

12:40 - Networking luncheon

SMART LABS & LABORATORY

13:30 – We have reached a tipping point in drug discovery. Start planning for fewer labs and more computers!

• Computational biology is producing insights comparable or sometimes better than wet lab approaches.
• This includes structural modelling, quasi-mechanistic modelling, predictive (AI/ML) algorithms, and even causal inferences.
• Several large Pharma companies and start-ups have responded and are significantly investing in modeling-first approaches.
• However, in the next 2-3 years modelling-first approaches will become a critical requirement of the workflow, for scientists to remain competitive.
• This talk discusses the above points from both technology and industry perspectives, and proposes that the adoption chasm has already been crossed.  

RAMINDERPAL SINGH, Founder, Incubate.bio (UK)

BLOCKCHAIN AND BIG DATA

14:00 – DISCUSSION WITH EXPERTS: Blockchain and Big Data in Pharma industry 4.0

• Challenges like data inconsistency, increasing customer expectation towards privacy, transparency, security and traceability?
• Implementation DO’s and DON’T’s on Blockchain products?
• How Blockchain helps to decrease the number of Pharma frauds?
• Blockchain growth in the next 5 years?
• How Big data speeding up the drug discovery?
• In what way Big data give hands in strategic planning and smart decision-making?
• What are preferable solutions for data integration and storage, data quality, security and privacy of data?

Moderator:
SIDDHI TRIVEDI, Founder, Beyond Identity (UK)

Panellists:
RASHMI HEGDE, Vice President Medical, Cipla
HRISHIKESH NASHIKKAR, Associate Director Blockchain, Novartis
KISHAN BARCHHA, Co-Founder, EasyCups

14:50 – Afternoon Tea/Coffee

DIGITALIZATION, RWE AND RWD

15:10 - DISCUSSION WITH EXPERTS:  Significance of Digitalization in Pharma

• How is digital transformation impacting the Pharma Industries?
• How can your company prepare for this digital transformation wave?
• Challenges and opportunities in moving to digitalization?
• How patients are involved in digital age in Pharma industry? Is their information secured? What is to be done?
• Customized services by smart innovation like apps, smart watch etc.....
• Commercial model evolution using digital in branded generics markets
• Zero Trust with Layered Defense

Moderator:
SANJAY GOHIL, Director, Futures.health (UK)

Panellists:
NEHA MISHRA, Associate Director, Service Delivery, Novartis
NAGENDRA KRISHNA SINGH, Associate Director - PD & Tech Transfer, Dr. Reddy's Laboratories
ANKEET BHAT, Chief Strategy Officer, MapmyIndia
NEHA GUPTA, Senior Digital Product Owner Strategy and Transformation, Ipsen (UK)
DEBASHISH ROY, Head- Digital Innovation & Strategic Initiatives, Abbott
ASHUTOSH MITTAL, Head – Global Quality Digital & Program Leader – Digital Transformation, Biocon
JEFF KIM, Life Sciences Business Consulting Executive, EPAM Systems (US)

16:10 – DISCUSSION WITH EXPERTS: RWD and RWE drive in Pharma

• How Pharma will handle complexity of data in RWD?
• Discussing how the RWE helps to get custom-made treatments and drug therapies for patients
• What helps us to have a better understanding about data quality and data privacy?
• RWE gives efficient and cost-effective clinical trials? How?
• What are complications will rise by inserting new data source? And it leads to breakup in data?
• Obtaining patient-centric using RWE
• What kind of changes needed to be place in RWE?
• Compelling with regulatory
• Market access for innovative medicines in emerging markets

Moderator:
VISHVAJIT M KARANDIKAR, Business Unit Head -Parenteral Nutrition, Fresenius Kabi

Panellists:
MYLES FURNACE, Real World Evidence Director, Global Medical Affairs, Ipsen (UK)
KAVITHA SRINIVASULU, Head of Cyber Security & Data Privacy, GAVS Technologies
KAVITA LAMROR, Director, Real World Investigator, Sanofi
LALIT RAUTE, Regional Senior Manager - Market Access, Johnson & Johnson
NITIN DHAVATE, Country Head - Data Privacy (India, South Asia, Sub-Saharan Africa), Novartis

17:00 - End of conference